SUTRO BIOPHARMA, INC.
Ticker: 1382101
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 9.84-32.2% | 14.52+49.8% | 9.69-84.8% | 63.75+266.4% | 17.40+104.2% | 8.52-66.9% | 25.71+97.6% | 13.01 |
| Total Income | 9.84-32.2% | 14.52+49.8% | 9.69-84.8% | 63.75+266.4% | 17.40+104.2% | 8.52-66.9% | 25.71+97.6% | 13.01 |
| EXPENSES | ||||||||
| Expenditure | 39.73-10.1% | 44.18-24.0% | 58.15-13.3% | 67.09-21.9% | 85.91+12.4% | 76.44+2.8% | 74.39+6.9% | 69.60 |
| Tax | 0.00+100.0% | -0.02 | 0.00+100.0% | -0.02 | — | 0.00-100.0% | 0.01 | — |
| PROFIT | ||||||||
| PBT | -38.53-0.1% | -38.50+32.3% | -56.86-393.6% | -11.52 | — | -48.79-1.6% | -48.01+17.5% | -58.21 |
| Net Profit | -38.53-0.1% | -38.48+32.3% | -56.86-394.4% | -11.50+84.9% | -75.97-55.7% | -48.79-1.6% | -48.02+17.5% | -58.21 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00%-94.75pp | -5.25%+94.75pp | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00%-81.96pp | -18.04%+81.96pp | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -2.33+20.7% | -2.94-338.8% | -0.67-378.6% | -0.14+84.6% | -0.91-54.2% | -0.59+0.0% | -0.59+37.9% | -0.95 |
Corporate Events
Board MeetingSTRO
20265Jun
Board Meeting
Annual Meeting of Stockholders to elect three Class II direc…
SEC Filing ↗